Long-term treatment retention in West Virginia’s comprehensive opioid addiction treatment (COAT) program

BACKGROUND: The United States continues to experience an opioid epidemic of unprecedented proportions despite FDA approval of life saving medications, such as buprenorphine. This paper describes a novel group-based buprenorphine treatment model and summarizes patient characteristics and treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lander, Laura R., Zheng, Wanhong, Hustead, Jeremy D., Mahoney, James J., Berry, James H., Marshalek, Patrick, Winstanley, Erin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409552/
https://www.ncbi.nlm.nih.gov/pubmed/32058182
http://dx.doi.org/10.1016/j.jns.2020.116712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409552/
https://www.ncbi.nlm.nih.gov/pubmed/32058182
http://dx.doi.org/10.1016/j.jns.2020.116712

Ejemplares similares